Stock analysts at StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR – Get Free Report) in a note issued to investors on Friday. The firm set a “hold” rating on the medical device company’s stock.
Avinger Price Performance
Shares of NASDAQ:AVGR opened at $0.87 on Friday. Avinger has a 1-year low of $0.76 and a 1-year high of $5.45. The firm’s 50 day simple moving average is $1.04 and its two-hundred day simple moving average is $1.95. The company has a market capitalization of $1.47 million, a P/E ratio of -0.05 and a beta of 1.17.
Avinger (NASDAQ:AVGR – Get Free Report) last released its earnings results on Thursday, August 8th. The medical device company reported ($2.82) EPS for the quarter, missing the consensus estimate of ($0.43) by ($2.39). The firm had revenue of $1.85 million for the quarter, compared to analysts’ expectations of $2.55 million. On average, sell-side analysts anticipate that Avinger will post -4.69 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
About Avinger
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Further Reading
- Five stocks we like better than Avinger
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Investing In Automotive Stocks
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.